Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Non-invasive physical plasma for preventing radiation dermatitis in breast cancer: Results from an intrapatient-randomised double-blind placebo-controlled trial.
Dejonckheere CS, Layer JP, Nour Y, Layer K, Glasmacher A, Wiegreffe S, Fuhrmann A, Caglayan L, Grau F, Sarria GR, Scafa D, Koch D, Heimann M, Leitzen C, Köksal MA, Röhner F, Müdder T, Dejonckheere E, Schmeel FC, Anzböck T, Lindner K, Bachmann A, Abramian A, Kaiser C, Faridi A, Mustea A, Giordano FA, Stope MB, Schmeel LC. Dejonckheere CS, et al. Clin Transl Radiat Oncol. 2023 Nov 4;44:100699. doi: 10.1016/j.ctro.2023.100699. eCollection 2024 Jan. Clin Transl Radiat Oncol. 2023. PMID: 38021092 Free PMC article.
[Nintedanib for the treatment of radiation pneumonitis].
Dejonckheere CS, Höller U, Käsmann L. Dejonckheere CS, et al. Strahlenther Onkol. 2024 May;200(5):457-459. doi: 10.1007/s00066-024-02216-8. Epub 2024 Feb 29. Strahlenther Onkol. 2024. PMID: 38421432 German. No abstract available.
Non-Invasive Physical Plasma for Preventing Radiation Dermatitis in Breast Cancer: A First-In-Human Feasibility Study.
Dejonckheere CS, Torres-Crigna A, Layer JP, Layer K, Wiegreffe S, Sarria GR, Scafa D, Koch D, Leitzen C, Köksal MA, Müdder T, Abramian A, Kaiser C, Faridi A, Stope MB, Mustea A, Giordano FA, Schmeel LC. Dejonckheere CS, et al. Pharmaceutics. 2022 Aug 24;14(9):1767. doi: 10.3390/pharmaceutics14091767. Pharmaceutics. 2022. PMID: 36145515 Free PMC article.
Five-Fraction Stereotactic Radiotherapy for Brain Metastases-A Retrospective Analysis.
Layer JP, Layer K, Sarria GR, Röhner F, Dejonckheere CS, Friker LL, Zeyen T, Koch D, Scafa D, Leitzen C, Köksal M, Schmeel FC, Schäfer N, Landsberg J, Hölzel M, Herrlinger U, Schneider M, Giordano FA, Schmeel LC. Layer JP, et al. Among authors: dejonckheere cs. Curr Oncol. 2023 Jan 17;30(2):1300-1313. doi: 10.3390/curroncol30020101. Curr Oncol. 2023. PMID: 36826062 Free PMC article.
Risk assessment, surveillance, and nonpharmaceutical prevention of acute radiation dermatitis: results of a multicentric survey among the German-speaking radiation oncology community.
Layer K, Layer JP, Glasmacher AR, Sarria GR, Böhner AMC, Layer YL, Dejonckheere CS, Garbe S, Feyer P, Baumert BG, Schendera A, Baumann R, Krug D, Köksal MA, Koch D, Scafa D, Leitzen C, Hölzel M, Giordano FA, Schmeel LC; German-Speaking Radiation Dermatitis Survey Group. Layer K, et al. Among authors: dejonckheere cs. Strahlenther Onkol. 2023 Oct;199(10):891-900. doi: 10.1007/s00066-023-02074-w. Epub 2023 Apr 26. Strahlenther Onkol. 2023. PMID: 37099166 Free PMC article.
Objective, Clinician- and Patient-Reported Evaluation of Late Toxicity Following Adjuvant Radiation for Early Breast Cancer: Long-Term Follow-Up Results of a Randomised Series.
Dejonckheere CS, Abramian A, Lindner K, Bachmann A, Layer K, Anzböck T, Layer JP, Sarria GR, Scafa D, Koch D, Leitzen C, Kaiser C, Faridi A, Schmeel LC. Dejonckheere CS, et al. J Clin Med. 2023 Jun 22;12(13):4212. doi: 10.3390/jcm12134212. J Clin Med. 2023. PMID: 37445247 Free PMC article.
26 results